Dan Brennan
Stock Analyst at TD Cowen
(4.35)
# 376
Out of 5,114 analysts
120
Total ratings
55.79%
Success rate
16.59%
Average return
Main Sectors:
Stocks Rated by Dan Brennan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDXH MDxHealth | Maintains: Buy | $5 → $7 | $3.15 | +122.22% | 2 | Nov 13, 2025 | |
| WAT Waters | Maintains: Hold | $345 → $390 | $378.03 | +3.17% | 4 | Nov 5, 2025 | |
| EXAS Exact Sciences | Maintains: Buy | $74 → $90 | $101.82 | -11.61% | 7 | Nov 4, 2025 | |
| MYGN Myriad Genetics | Maintains: Hold | $8 → $9 | $6.55 | +37.40% | 2 | Nov 4, 2025 | |
| BRKR Bruker | Maintains: Hold | $40 → $42 | $46.48 | -9.64% | 2 | Nov 4, 2025 | |
| ILMN Illumina | Maintains: Hold | $110 → $115 | $134.78 | -14.68% | 13 | Oct 31, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $612 → $654 | $567.83 | +15.18% | 13 | Oct 23, 2025 | |
| DHR Danaher | Maintains: Buy | $250 → $260 | $224.84 | +15.64% | 6 | Oct 22, 2025 | |
| A Agilent Technologies | Maintains: Buy | $150 → $162 | $137.24 | +18.04% | 13 | Oct 14, 2025 | |
| GH Guardant Health | Maintains: Buy | $63 → $72 | $99.74 | -27.81% | 3 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $12 | $11.83 | +1.44% | 7 | Sep 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $15 | $17.00 | -11.76% | 1 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $27.94 | +14.53% | 1 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $110 | $140.44 | -21.67% | 4 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $8 → $2.5 | $3.43 | -27.11% | 4 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $74 | $64.46 | +14.80% | 2 | Feb 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $155 → $175 | $231.96 | -24.56% | 4 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $250 | $197.06 | +26.86% | 5 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $141 → $144 | $96.24 | +49.63% | 3 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $31 | $11.27 | +175.07% | 3 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $48 → $51 | $39.82 | +28.08% | 2 | Jul 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $56 | $6.69 | +737.07% | 1 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $57 → $32 | $16.05 | +99.38% | 4 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $545 → $546 | $209.45 | +160.68% | 4 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $13 → $15 | $1.84 | +715.22% | 1 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $207 → $232 | $173.77 | +33.51% | 6 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $770 → $880 | $1,402.51 | -37.26% | 3 | Oct 7, 2020 |
MDxHealth
Nov 13, 2025
Maintains: Buy
Price Target: $5 → $7
Current: $3.15
Upside: +122.22%
Waters
Nov 5, 2025
Maintains: Hold
Price Target: $345 → $390
Current: $378.03
Upside: +3.17%
Exact Sciences
Nov 4, 2025
Maintains: Buy
Price Target: $74 → $90
Current: $101.82
Upside: -11.61%
Myriad Genetics
Nov 4, 2025
Maintains: Hold
Price Target: $8 → $9
Current: $6.55
Upside: +37.40%
Bruker
Nov 4, 2025
Maintains: Hold
Price Target: $40 → $42
Current: $46.48
Upside: -9.64%
Illumina
Oct 31, 2025
Maintains: Hold
Price Target: $110 → $115
Current: $134.78
Upside: -14.68%
Thermo Fisher Scientific
Oct 23, 2025
Maintains: Buy
Price Target: $612 → $654
Current: $567.83
Upside: +15.18%
Danaher
Oct 22, 2025
Maintains: Buy
Price Target: $250 → $260
Current: $224.84
Upside: +15.64%
Agilent Technologies
Oct 14, 2025
Maintains: Buy
Price Target: $150 → $162
Current: $137.24
Upside: +18.04%
Guardant Health
Sep 25, 2025
Maintains: Buy
Price Target: $63 → $72
Current: $99.74
Upside: -27.81%
Sep 12, 2025
Maintains: Buy
Price Target: $10 → $12
Current: $11.83
Upside: +1.44%
Aug 6, 2025
Maintains: Buy
Price Target: $13 → $15
Current: $17.00
Upside: -11.76%
Jul 14, 2025
Initiates: Buy
Price Target: $32
Current: $27.94
Upside: +14.53%
May 1, 2025
Maintains: Buy
Price Target: $135 → $110
Current: $140.44
Upside: -21.67%
Mar 21, 2025
Maintains: Neutral
Price Target: $8 → $2.5
Current: $3.43
Upside: -27.11%
Feb 5, 2025
Reinstates: Buy
Price Target: $74
Current: $64.46
Upside: +14.80%
Nov 13, 2024
Maintains: Buy
Price Target: $155 → $175
Current: $231.96
Upside: -24.56%
Nov 7, 2024
Maintains: Buy
Price Target: $240 → $250
Current: $197.06
Upside: +26.86%
Nov 5, 2024
Maintains: Buy
Price Target: $141 → $144
Current: $96.24
Upside: +49.63%
Jul 29, 2024
Maintains: Buy
Price Target: $28 → $31
Current: $11.27
Upside: +175.07%
Jul 23, 2024
Maintains: Buy
Price Target: $48 → $51
Current: $39.82
Upside: +28.08%
May 13, 2024
Initiates: Buy
Price Target: $56
Current: $6.69
Upside: +737.07%
May 1, 2024
Downgrades: Hold
Price Target: $57 → $32
Current: $16.05
Upside: +99.38%
Dec 8, 2023
Maintains: Outperform
Price Target: $545 → $546
Current: $209.45
Upside: +160.68%
Mar 31, 2023
Upgrades: Outperform
Price Target: $13 → $15
Current: $1.84
Upside: +715.22%
Mar 1, 2021
Upgrades: Buy
Price Target: $207 → $232
Current: $173.77
Upside: +33.51%
Oct 7, 2020
Downgrades: Sell
Price Target: $770 → $880
Current: $1,402.51
Upside: -37.26%